Search research articles
Contact Us
Filters
Showing results (111-120 of 157) with videos related to
Page
of 16
Sort By:
The Journal of Clinical Investigation
|
July 2, 2019
N-Myc-mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancer
Adeline Berger, Nicholas J Brady, Rohan Bareja, et al.
Nature Communications
|
June 8, 2021
Temporal evolution of cellular heterogeneity during the progression to advanced AR-negative prostate cancer
Nicholas J Brady, Alyssa M Bagadion, Richa Singh, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 2, 2021
Plasma androgen receptor and response to adapted and standard docetaxel regimen in castration-resistant prostate cancer: A multicenter biomarker study
Vincenza Conteduca, Daniel Wetterskog, Elena Castro, et al.
European Urology Open Science
|
October 27, 2025
Real-life Use of Cabozantinib in Front-line therapy for Metastatic Renal Cell Carcinoma: The CabFRONT Study (Meet-URO 24)
Marco Stellato, Pierangela Sepe, Enrico Bronte, et al.
Journal of Clinical Medicine
|
June 26, 2020
Immune Modulation in Prostate Cancer Patients Treated with Androgen Receptor (AR)-Targeted Therapy
Vincenza Conteduca, Orazio Caffo, Emanuela Scarpi, et al.
Future Oncology (London, England)
|
October 6, 2015
Impact of visceral metastases on outcome to abiraterone after docetaxel in castration-resistant prostate cancer patients
Vincenza Conteduca, Orazio Caffo, Lucia Fratino, et al.
The Journal of Clinical Investigation
|
March 10, 2020
Genome-wide plasma DNA methylation features of metastatic prostate cancer
Anjui Wu, Paolo Cremaschi, Daniel Wetterskog, et al.
European Urology Open Science
|
February 22, 2024
Inherited Mutations in DNA Damage Repair Genes in Italian Men with Metastatic Prostate Cancer: Results from the Meet-URO 10 Study
Chiara Casadei, Emanuela Scarpi, Vincenza Conteduca, et al.
Therapeutic Advances in Urology
|
April 19, 2024
Assessing the effectiveness and safety of lenvatinib and everolimus in advanced renal cell carcinoma: insights from the RELIEVE study's analysis of heavily pretreated patients
Sebastiano Buti, Alessandro Olivari, Cristina Masini, et al.
The Oncologist
|
June 2, 2021
Prognostic Role of Circulating Tumor Cells in Metastatic Renal Cell Carcinoma: A Large, Multicenter, Prospective Trial
Umberto Basso, Antonella Facchinetti, Elisabetta Rossi, et al.
Page
of 16
Search research articles
Search
Showing results (111-120 of 157) with videos related to
Sort By:
Page
of 16
The Journal of Clinical Investigation
|
July 2, 2019
N-Myc-mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancer
Adeline Berger, Nicholas J Brady, Rohan Bareja, et al.
Nature Communications
|
June 8, 2021
Temporal evolution of cellular heterogeneity during the progression to advanced AR-negative prostate cancer
Nicholas J Brady, Alyssa M Bagadion, Richa Singh, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 2, 2021
Plasma androgen receptor and response to adapted and standard docetaxel regimen in castration-resistant prostate cancer: A multicenter biomarker study
Vincenza Conteduca, Daniel Wetterskog, Elena Castro, et al.
European Urology Open Science
|
October 27, 2025
Real-life Use of Cabozantinib in Front-line therapy for Metastatic Renal Cell Carcinoma: The CabFRONT Study (Meet-URO 24)
Marco Stellato, Pierangela Sepe, Enrico Bronte, et al.
Journal of Clinical Medicine
|
June 26, 2020
Immune Modulation in Prostate Cancer Patients Treated with Androgen Receptor (AR)-Targeted Therapy
Vincenza Conteduca, Orazio Caffo, Emanuela Scarpi, et al.
Future Oncology (London, England)
|
October 6, 2015
Impact of visceral metastases on outcome to abiraterone after docetaxel in castration-resistant prostate cancer patients
Vincenza Conteduca, Orazio Caffo, Lucia Fratino, et al.
The Journal of Clinical Investigation
|
March 10, 2020
Genome-wide plasma DNA methylation features of metastatic prostate cancer
Anjui Wu, Paolo Cremaschi, Daniel Wetterskog, et al.
European Urology Open Science
|
February 22, 2024
Inherited Mutations in DNA Damage Repair Genes in Italian Men with Metastatic Prostate Cancer: Results from the Meet-URO 10 Study
Chiara Casadei, Emanuela Scarpi, Vincenza Conteduca, et al.
Therapeutic Advances in Urology
|
April 19, 2024
Assessing the effectiveness and safety of lenvatinib and everolimus in advanced renal cell carcinoma: insights from the RELIEVE study's analysis of heavily pretreated patients
Sebastiano Buti, Alessandro Olivari, Cristina Masini, et al.
The Oncologist
|
June 2, 2021
Prognostic Role of Circulating Tumor Cells in Metastatic Renal Cell Carcinoma: A Large, Multicenter, Prospective Trial
Umberto Basso, Antonella Facchinetti, Elisabetta Rossi, et al.
Page
of 16